0001209191-19-020631.txt : 20190320 0001209191-19-020631.hdr.sgml : 20190320 20190320174739 ACCESSION NUMBER: 0001209191-19-020631 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190318 FILED AS OF DATE: 20190320 DATE AS OF CHANGE: 20190320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoerter Steven L. CENTRAL INDEX KEY: 0001533451 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38219 FILM NUMBER: 19695443 MAIL ADDRESS: STREET 1: 2525 28TH STREET, SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001654151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200299725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TOTTEN POND ROAD CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-209-6400 MAIL ADDRESS: STREET 1: 500 TOTTEN POND ROAD CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC DATE OF NAME CHANGE: 20150928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-18 0 0001654151 Deciphera Pharmaceuticals, Inc. DCPH 0001533451 Hoerter Steven L. C/O DECIPHERA PHARMACEUTICALS, INC. 500 TOTTEN POND ROAD WALTHAM MA 02451 1 1 0 0 President & CEO Common Stock 2019-03-18 4 A 0 22000 0.00 A 22000 D Common Stock 2019-03-18 4 A 0 30000 0.00 A 52000 D Stock Option (Right to Buy) 25.40 2019-03-18 4 A 0 400000 0.00 A 2029-03-17 Common Stock 400000 400000 D The reporting person was awarded 22,000 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock. The Restricted Stock Units shall vest in full on March 18, 2020, subject to the reporting person's continuous service with the Company through such date. The Restricted Stock Units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. The reporting person was awarded 30,000 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock. The Restricted Stock Units shall vest in four (4) equal annual installments beginning on March 18, 2020, subject to the reporting person's continuous service with the Company through such dates. The Restricted Stock Units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. 25% of the options shall vest on March 18, 2020, and the remaining options shall vest in equal monthly installments over the following three years, subject to continued service through such dates. /s/ Amanda Stastny, Attorney-in-Fact 2019-03-20